“Although our data are preliminary, we did not find statistical
differences in the prevalence of COVID-19 antibodies in people with
type 1 diabetes and the general population,” Liping Yu, an associate
research professor of pediatrics at the Barbara Davis Center for
Diabetes, University of Colorado Anschutz Medical Campus, and
colleagues wrote.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045